Biotechnology News

Medicovestor announces FDA Fast Track designation for MC001, its first-in-class chemoimmunotherapy ADC for pancreatic cancer.

Expands Kane Biotech’s commercial footprint and access to the revyve® product line across Canada WINNIPEG, Manitoba, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”,...

PolarityBio® announced it received the Highest Scoring Abstract Award in the Clinical Research category at the Symposium on Advanced Wound Care Fall 2026.

YOL104-2 is a bioengineered, trivalent, multifunctional peptibody incorporating a core interferon-mimetic with the potential to be a first-in-class therapy for Ocular Surface Squamous Neoplasia (OSSN)...

MAINZ, Germany, October 20, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2026 on Tuesday, November 3, 2026....

MAINZ, Deutschland, 20. Oktober 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird am Dienstag, den 3. November 2026, die Ergebnisse für das dritte Quartal...

Orikine Presents Preclinical Data Demonstrating Sustained Myeloid Reprogramming and Disease Control with ORK1 in Inflammatory Bowel Disease at UEG Week

Former Pfizer Chief Scientific Officer and President of Worldwide Research, Development and Medical brings deep experience translating scientific innovation into life-changing medicines for patients ...

Enhanced process increases manufacturing productivity and frees up capacity to support growing demand across Alvotech’s biosimilars portfolio REYKJAVIK, Iceland and LONDON, UK (October 20, 2026) -...

REYKJAVÍK (20. október 2026) - Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að Matvæla- og lyfjastofnun Bandaríkjanna (FDA) hefði samþykkt nýja aðferð við framleiðslu á Simlandi, hliðstæðu...